Skip to main content

Pharming Group N.V.

PHAR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001828316

No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Pharming Group N.V. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of PHAR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders330
Shares29.5K25.8K−3.67K (−12.4%)
Value$325.1K$295.6K−$29.5K (−9.1%)

New holders (0)

Institutions that held Pharming Group N.V. at the end of Q1 2023 but not at the end of Q4 2022.

None.

Sold out (0)

Institutions that held Pharming Group N.V. at the end of Q4 2022 and filed for Q1 2023 without it.

None.